Live Breaking News & Updates on Yujiros Hata|Page 5

Stay updated with breaking news from Yujiros hata. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

IDEAYA Announces Clinical Collaboration to Evaluate IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer

Trial will evaluate IDE161, IDEAYA s investigational PARG inhibitor, in combination with KEYTRUDA® , Merck s anti-PD-1 therapy, in patients with MSI-high and MSS endometrial cancer Potential. ....

United States , Darrin Beaupre , Andres Ruiz Briseno , Yujiros Hata , Us Food Drug Administration Fast , Biosciences Inc , Merck Co Inc , Exchange Commission , Merck Sharp Dohme , Chief Medical Officer , Chief Executive Officer , Drug Administration Fast Track , Merck Sharp , Annual Report , Investor Relations ,

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Position Boosted by Boone Capital Management LLC

Boone Capital Management LLC lifted its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 15.0% during the third quarter, Holdings Channel.com reports. The fund owned 570,682 shares of the company’s stock after purchasing an additional 74,249 shares during the period. IDEAYA Biosciences accounts for about 4.9% of Boone Capital Management LLC’s […] ....

Los Angeles , United States , Werner Helicase , Briseno Andres Ruiz , Yujiros Hata , Boone Capital Management , Kokusai Asset Management Co , Life Insurance Co , Securities Exchange Commission , Goldman Sachs Group , Biosciences Company Profile , Los Angeles Capital Management , Royal Bank , Jpmorgan Chase Co , Biosciences Inc , Holdings Channel , Mitsubishi Ufj , Free Report , Capital Management , Angeles Capital Management , State Retirement System , Asset Management , One Financial , Get Free Report , Exchange Commission , Pol Theta Helicase ,

Boone Capital Management LLC Acquires 74,249 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)

Boone Capital Management LLC lifted its position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 15.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 570,682 shares of the company’s stock after purchasing an additional 74,249 shares during the period. […] ....

United States , Yujiros Hata , Briseno Andres Ruiz , Werner Helicase , Boone Capital Management , Securities Exchange Commission , Life Insurance Co , Royal Bank , Goldman Sachs Group , Halpern Financial Inc , Tucker Asset Management , Biosciences Inc , Jpmorgan Chase Co , Exchange Commission , China Universal Asset Management Co , Free Report , Capital Management , Universal Asset Management , Asset Management , Trading Down , Get Free Report , Pol Theta Helicase ,

IDEAYA Biosciences (NASDAQ:IDYA) PT Raised to $57.00 at JPMorgan Chase & Co.

IDEAYA Biosciences (NASDAQ:IDYA – Free Report) had its price objective boosted by JPMorgan Chase & Co. from $51.00 to $57.00 in a report issued on Friday, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. Several other research analysts have also weighed in on the company. Royal Bank of Canada […] ....

Briseno Andres Ruiz , Yujiros Hata , Halpern Financial Inc , Jpmorgan Chase Co , China Universal Asset Management Co , Royal Bank , Biosciences Inc , Life Insurance Co , Goldman Sachs Group , Securities Exchange Commission , Biosciences Company Profile , Free Report , One Financial , Get Free Report , Exchange Commission , Universal Asset Management , Ideaya Biosciences , Nasdaq Idya , Boost Price Target , Jpmorgan Chase Co ,

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Given Average Rating of "Buy" by Analysts

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Given Average Rating of "Buy" by Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Briseno Andres Ruiz , Yujiros Hata , Metlife Investment Management , Jpmorgan Chase Co , Royal Bank , Goldman Sachs Group , Ideaya Biosciences Inc , Biosciences Inc , Dimensional Fund Advisors , Securities Exchange Commission , Swiss National Bank , Get Free Report , One Financial , Exchange Commission , National Bank , Life Investment Management , Fund Advisors , Get Free ,